Entity Common Stock, Shares Outstanding of ImmunityBio, Inc. from 31 Aug 2015 to 19 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ImmunityBio, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Aug 2015 to 19 Feb 2026.
  • ImmunityBio, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 19 Feb 2026 was 1,028,111,456, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ImmunityBio, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 1,028,111,456 +174,669,319 +20% 19 Feb 2026 10-K 23 Feb 2026 2025 FY
Q3 2025 984,965,179 +288,133,883 +41% 30 Oct 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 945,254,685 +248,721,267 +36% 31 Jul 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 853,442,137 +179,489,859 +27% 27 Feb 2025 10-K 03 Mar 2025 2024 FY
Q3 2024 696,831,296 +29,125,928 +4.4% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 696,533,418 +240,286,052 +53% 07 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 673,952,278 +237,967,749 +55% 14 Mar 2024 10-K 19 Mar 2024 2023 FY
Q3 2023 667,705,368 +267,401,262 +67% 03 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 456,247,366 +55,943,260 +14% 04 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 435,984,529 +38,027,767 +9.6% 05 May 2023 10-Q 11 May 2023 2023 Q1
Q3 2022 400,304,106 +2,709,571 +0.68% 04 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 400,304,106 +9,147,593 +2.3% 04 Aug 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 397,956,762 +288,612,189 +264% 05 May 2022 10-Q 10 May 2022 2022 Q1
Q3 2021 397,594,535 +289,001,952 +266% 10 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 391,156,513 +283,186,050 +262% 10 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 109,344,573 +10,861,412 +11% 03 Mar 2021 10-K 04 Mar 2021 2020 FY
Q3 2020 108,592,583 +10,225,399 +10% 05 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 107,970,463 +9,662,604 +9.8% 05 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 98,483,161 +19,395,427 +25% 20 Mar 2020 10-K 25 Mar 2020 2019 FY
Q3 2019 98,367,184 +19,141,101 +24% 01 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 98,307,859 +19,099,983 +24% 02 Aug 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 79,087,734 +56,214 +0.07% 08 Mar 2019 10-K 13 Mar 2019 2018 FY
Q3 2018 79,226,083 -229,056 -0.29% 05 Nov 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 79,207,876 -232,824 -0.29% 02 Aug 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 79,031,520 -3,265,101 -4% 07 Mar 2018 10-K 12 Mar 2018 2017 FY
Q3 2017 79,455,139 -2,920,350 -3.5% 31 Oct 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 79,440,700 -2,871,064 -3.5% 01 Aug 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 82,296,621 +365,623 +0.45% 10 Mar 2017 10-K 15 Mar 2017 2016 FY
Q3 2016 82,375,489 +1,233,986 +1.5% 03 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 82,311,764 09 Aug 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 81,930,998 25 Mar 2016 10-K 30 Mar 2016 2015 FY
Q3 2015 81,141,503 31 Aug 2015 10-Q 10 Sep 2015 2015 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.